ID: ALA2419516

Max Phase: Preclinical

Molecular Formula: C20H19N5O3S

Molecular Weight: 409.47

Molecule Type: Small molecule

Representations

Canonical SMILES:  Nc1ccc(S(=O)(=O)c2ccc(CNC(=O)N3Cc4ccncc4C3)cc2)cn1

Standard InChI:  InChI=1S/C20H19N5O3S/c21-19-6-5-18(11-23-19)29(27,28)17-3-1-14(2-4-17)9-24-20(26)25-12-15-7-8-22-10-16(15)13-25/h1-8,10-11H,9,12-13H2,(H2,21,23)(H,24,26)

Standard InChI Key:  NMNMXZAMLXAEMU-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 409.47

Molecular Weight (Monoisotopic): 409.1209

AlogP: 2.12

#Rotatable Bonds: 4

Polar Surface Area: 118.28

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.82

CX Basic pKa: 4.72

CX LogP: 0.79

CX LogD: 0.79

Aromatic Rings: 3

Heavy Atoms: 29

QED Weighted: 0.68

Np Likeness Score: -1.10

References

1. Dragovich PS, Bair KW, Baumeister T, Ho YC, Liederer BM, Liu X, Liu Y, O'Brien T, Oeh J, Sampath D, Skelton N, Wang L, Wang W, Wu H, Xiao Y, Yuen PW, Zak M, Zhang L, Zheng X..  (2013)  Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).,  23  (17): [PMID:23899614] [10.1016/j.bmcl.2013.06.090]

Source

Source(1):

• Scientific Literature